D-0964-2015 Class III Terminated
FDA drug recall D-0964-2015 was initiated by Reckitt Benckiser LLC on Nov 10, 2014 and is designated Class III. Reason for recall: Defective container: A customer complaint revealed the presence of a defective seal on the top of a Mucinex pouch The recall status is terminated (terminated Mar 30, 2018). Affected quantity: 155 cases (2000 pouches of 2 tablets per case).
Recall details
- Product Type
- Drugs
- Report Date
- Apr 29, 2015
- Initiation Date
- Nov 10, 2014
- Termination Date
- Mar 30, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 155 cases (2000 pouches of 2 tablets per case)
Product description
Mucinex DM (guaifenesin 600mg and dextromethorphan HBr 30mg), extended-release bi-layer tablets, 2 tablets per pouch (NDC 63824-056-72), OTC, Distributed by Reckitt Benckiser, Parsippany, NJ 07054-0224 Made in England
Reason for recall
Defective container: A customer complaint revealed the presence of a defective seal on the top of a Mucinex pouch
Distribution pattern
Nationwide
Code information
Lot BD375 exp 06/2016; BD566, BD661 exp. 08/2016
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0964-2015
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Reckitt Benckiser LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.